We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Alpharma, Ivax Reach Deal on Generic Neurontin
Alpharma, Ivax Reach Deal on Generic Neurontin
February 18, 2005
Generic firm Ivax has signed a settlement agreement with rival Alpharma that will enable it to launch a generic version of Pfizer’s Neurontin before Alpharma’s 180 days of marketing exclusivity expires.